title: Formation of free choline in brain tissue during in vitro energy deprivation.
abstract: Free choline and ATP contents were measured in Mongolian gerbil hippocampal slices (tissue) and incubation media (media) during exposure to 30 min of aglycemia, high potassium, anoxia, or ischemia. Changes in choline levels reflected the degree of energy reduction, lower ATP levels being associated with high choline (4-fold increase during exposure to high potassium and anoxia, and 11-fold increase during ischemia). Media (extracellular) choline was particularly affected and increased about twofold during relatively mild energy depletion (e.g., aglycemia), but tissue choline content was less sensitive to energy reduction. A plot of choline vs. ATP levels indicated a nonlinear correlation, and the sharp increase in choline occurred when ATP values fell to about 2.5 nmol/mg of protein. Inhibition of acetylcholine sterase by 10 microM physostigmine during ischemia did not prevent an increase in choline contents but rather enhanced them, indicating that acetylcholine hydrolysis was not the source of free choline. Formation of free choline was Ca2+ independent. These findings suggest the involvement of phospholipase D and phosphatidylcholine hydrolysis in free choline formation during energy stress. The extent of choline formation may be an indicator of the degree of membranal damage, which in turn reflects damage to the metabolic machinery of the cell.
authors.affiliation: Department of Biochemistry and Molecular Biology, School of Medicine, University of Minnesota, Duluth 55812.
authors.forename: B
authors.initials: B
authors.lastname: Djuricic
authors.forename: S R
authors.initials: SR
authors.lastname: Olson
authors.forename: H M
authors.initials: HM
authors.lastname: Assaf
authors.forename: T S
authors.initials: TS
authors.lastname: Whittingham
authors.forename: W D
authors.initials: WD
authors.lastname: Lust
authors.forename: L R
authors.initials: LR
authors.lastname: Drewes
mesh_terms: D000110:Acetylcholinesterase / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D002794:Choline / Q000378:metabolism*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004734:Energy Metabolism; D005849:Gerbillinae; D005947:Glucose / Q000008:administration & dosage; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D007003:Hypoglycemia / Q000378:metabolism; D000860:Hypoxia / Q000378:metabolism; D066298:In Vitro Techniques; D002546:Ischemic Attack, Transient / Q000378:metabolism; D010100:Oxygen / Q000008:administration & dosage; D011188:Potassium / Q000494:pharmacology
chemical_list: D002800:Cholinesterase Inhibitors; D000255:Adenosine Triphosphate; D000110:Acetylcholinesterase; D005947:Glucose; D002794:Choline; D011188:Potassium; D010100:Oxygen; D002118:Calcium